Hepatitis B Infection
Infectious Diseases
5
Pipeline Programs
3
Companies
4
Clinical Trials
1
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
1
0
3
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 3 programs with unclassified modality
On Market (1)
Approved therapies currently available
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Bristol Myers SquibbPRINCETON, NJ
1 program1
BARACLUDE(Entecavir)Phase 4Small Molecule1 trial
Active Trials
HM
GC BiopharmaKorea - Yongin
2 programs1
1
GC1102 80,000 IUPhase 2/31 trial
GC1102 50,000 IUPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Hua MedicineTelbivudine
Bristol Myers SquibbEntecavir
GC BiopharmaGC1102 80,000 IU
GC BiopharmaGC1102 50,000 IU
Clinical Trials (4)
Total enrollment: 831 patients across 4 trials
Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus
Start: Mar 2009Est. completion: Jul 2013700 patients
Phase 4Completed
Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection
Start: Nov 2006Est. completion: Mar 2011131 patients
Phase 4Completed
HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102
Start: Mar 2018Est. completion: Sep 2022
Phase 2/3Unknown
A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients
Start: Feb 2015Est. completion: May 2016
Phase 2Completed
Related Jobs in Infectious Diseases
Senior Recruiter
Invivyd
New Haven, CT (Northeast preferred)
5h ago
$120K - $160K/yr
Senior Associate Scientist (contract), Upstream Polysaccharide Process Development
VaxCyte
San Carlos, California, United States
8h ago
$56/hr
Senior Associate Scientist (contract), Polysaccharide Analytical Development
VaxCyte
San Carlos, California, United States
8h ago
$56/hr
Director, Program Management
Metaphore Biotechnologies
Somerville, MA USA
12h ago
$179K - $237K/yr
First Line Sales Leader (Medan)
GSK
Indonesia - Sumatera Utara
Yesterday
General Worker
GSK
Pakistan - Sindh - Karachi
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space